In Life Science Daily News, Exagen CSO Michael Mahler, PhD, explains how deep B‑cell depletion and IgG blockade are redefining autoantibodies—from diagnostic clues to signals of treatment response and immune reconstitution. Questions? Comment or contact Michael. #Autoantibodies #BCellTherapy